Navigation Links
HIV Patients May Be at Risk of Heart Problems When Taking Protease Inhibitor Drugs

successful treatment of HIV viral infection and control of AIDS. But hopefully our findings will save lives by alerting the physician to yet another side effect associated with this class of drug."

Dr. Ackerman is director of Mayo Clinic's Long QT Syndrome Clinic and Sudden Death Genomics Laboratory that specializes in various diseases and conditions that make a person vulnerable to sudden death by a ventricular arrhythmia.

There are several specific actions physicians can take to use this new information wisely, Drs. Ackerman and Badley say. The first is to screen by electrocardiogram for heart effects in vulnerable patients. The second is to be alert for multiple drug therapy situations, because certain drug-drug combinations could trigger the adverse heart side effects.

Background of the Discovery

Dr. Badley's research group earlier discovered that protease inhibitors affect "pore function" of "channels" in a specific cell type they were studying. Pore function in channels permits the exchange of biochemical signals within and between cells. After hearing of a case of heart rhythm disturbances in a patient taking protease inhibitors, the researchers looked for evidence of other patients with similar experiences. To do this, they used the U.S. Food and Drug Administration's voluntary drug side-effect database, the Adverse Event Reporting System. They identified 24 cases of heart rhythm disturbances -- all of which were associated with protease inhibitors.

They investigated the hypothesis that the widely-used protease inhibitors may, in fact, be linked to the development of heart rhythm problems through the mechanism of blocking a channel. Ultimately researchers from the University of Wisconsin led by Craig January, M.D., Ph.D., discovered that protease inhibitors do block these key channels.

"Our findings suggest that as a class, protease inhibitors may predispose individuals to QT interval problems or torsade de poi
'"/>

Source:Mayo Clinic


Page: 1 2 3

Related biology news :

1. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
2. Emory Eye Center Implants Its First Retinal Chips In Patients With Retinitis Pigmentosa
3. Implanted Devices Detect High-Risk Heart Failure Patients
4. Rush Physicians Using Gene Therapy For Heart Patients With Moderate To Severe Chest Pains Who Do Not Benefit From Other Treatments
5. Gene Signatures Predict Interferon Response For Multiple Sclerosis Patients
6. Bevacizumab Combined With Chemotherapy Improves Progression-Free Survival for Patients With Advanced Breast Cancer
7. Single-donor Islet Transplantation Procedure Shows Promise For Patients With Type 1 Diabetes
8. IMF Launches World’s First DNA Database for Myeloma Patients
9. Patients now surviving once-fatal immune disease
10. Patients and their doctors have different perceptions about HIV and its treatment
11. Patients to benefit from novel technology revolutionizing high-speed molecular imaging
Post Your Comments:
(Date:12/19/2014)... 2014   LaunchKey , the first decentralized mobile authentication ... of Things era, today announced the close of $3 ... led by Metamorphic Ventures with participation from ENIAC Ventures, ... others.  LaunchKey has raised $4 million to date, and ...
(Date:12/17/2014)... Dec. 16, 2014 Research and Markets ( ... "Global Chemical Sensor Market 2015-2019" report to their ... One major trend upcoming in this market is ... Chemical sensors help in recording of patient data for ...
(Date:12/11/2014)... Dec. 10, 2014  That blood pressure plays a role in ... – the medical term for high blood pressure – was ... the inflatable cuff that,s used in measuring blood pressure was ... nothing new about hypertension, its triggers and its effects. In ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4
... German . , It is currently estimated that ... those reserves where extraction is cost-effective will only flow for ... Institute for Coal Research and at the Max Planck Institute ... worthwhile to tap into previously unused resources. They have developed ...
... concept of altruism has long been debated in philosophical ... debate. From the perspective of natural selection, altruism ... likelihood of a relative,s survival and reproduction increases the ... Social behavior, kin recognition, and altruism are well known ...
... with colleagues in Sweden and abroad, have identified an entirely ... inhibits formation of new blood vessels. Inhibiting the formation of ... cancer treatment. The study is published in the November issue ... the formation of new blood vessels, is strictly regulated by ...
Cached Biology News:Energy-saving powder 2Energy-saving powder 3Can a plant be altruistic? 2New mechanism explains how the body prevents formation of blood vessels 2
(Date:1/22/2015)... January 22, 2015 Controlled Substance Compliance ... which helps companies check the legal requirements around using ... to China. , As their international operations expand ... adopting software solutions built as a result of the ...
(Date:1/22/2015)... BRUNSWICK , Nueva Jersey , 22 de ... Award for Biomedical Research abre hoy su llamada a ... personas cuya investigación científica ha hecho, o tiene el ... la salud humana. Las nominaciones se aceptarán hasta el ...
(Date:1/22/2015)... , Jan. 22, 2015   GenoSpace , a precision medicine ... to enable the broad use of genomic, imaging and other ... appointment of Michelle Munson , CEO of Aspera, an ... Logo - http://photos.prnewswire.com/prnh/20150122/170713 "We ...
(Date:12/24/2014)... Dec. 24, 2014  United Therapeutics Corporation (NASDAQ: ... MDT ) has submitted a pre-market approval application ... the use of Medtronic,s SynchroMed ® II implantable ... use with United Therapeutics, Remodulin ® (treprostinil) Injection ...
Breaking Biology Technology:Global Compliance Service for Controlled Substances to Expand to China 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 3El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 4GenoSpace Expands Board with Appointment of Michelle Munson 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4
... is pleased to announce that it has been selected by ... United Kingdom in the prestigious 2011 awards programme. Trimega beat ... Country Representatives and will now compete for a coveted Ruban ... Trimega,s pioneering use of dual testing of hair to determine ...
... College Park, Md. (May 6, 2011) A bold new ... silicon and may boost their efficiency is the ... and the Institute of Physics, photovoltaic group at the Academy ... for low-cost, high-yield industrial production of solar panels from abundant ...
... America, Inc . (OTC BB: CBAI, CBAID) announced today that the ... its shareholders voting in a recent proxy vote,  is the opening ... one for one hundred reverse split reduces the number of shares ... "D" will be placed on the ticker symbol for 20 business ...
Cached Biology Technology:Trimega Laboratories Honoured to Represent UK at the European Business Awards 2Trimega Laboratories Honoured to Represent UK at the European Business Awards 3'Swiss cheese' design enables thin film silicon solar cells with potential for higher efficiencies 2
...
...
TNM-FH Insect Medium 1 liter...
D.R. Harper (1993) • Includes: essential information on taxonomy, culture and safe handling of viruses, immunology, monoclonal antibodies, antivirals and vaccines....
Biology Products: